ORGO News and Press, Organogenesis Holdings Inc.

CANTON, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and spor...

CANTON, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that the U.S. Food and Drug Administration (FDA) ...

Issued on behalf of Conexeu Sciences Inc. A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in. NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Biotech ...

Issued on behalf of Conexeu Sciences Inc. A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it. NEW...

2026-06-15 04:32:19 ET ... Read the full article on Seeking Alpha For further details see: Organogenesis: Mesmerized By Wound Care Struggles, Upcoming ReNu Blockbuster Overlooked

The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire Issued on behalf of Conexeu Sciences Inc. A newly listed regenerative-tissue company has put its lead breast-reconstruction matrix on the bench at one of the world ' s...

2026-05-26 10:20:04 ET Ironwood Pharmaceuticals: A Contrarian Buy Opportunity Ironwood Pharmaceuticals: Still A Profitable Opportunity GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity Notable healthcare headlines for the week: UnitedHealth, Boston ...

2026-05-08 13:28:17 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-08 05:22:10 ET More on Organogenesis Holdings Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call Transcript Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight Organogenesis Facing Hard Times As It Adjusts To CMS Rule Changes Organogene...

2026-05-08 05:21:16 ET Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call May 7, 2026 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call Transcript